<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0003613'>Antiphospholipid antibodies</z:hpo> are found in 15% of women with <z:e sem="disease" ids="C0000809" disease_type="Disease or Syndrome" abbrv="">recurrent miscarriage</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>These women have only a 10% live birth rate in subsequent pregnancies in which no pharmacological treatment is given </plain></SENT>
<SENT sid="2" pm="."><plain>Pregnancy loss is often attributable to uteroplacental insufficiency subsequent to placental <z:mp ids='MP_0005048'>thrombosis</z:mp> </plain></SENT>
<SENT sid="3" pm="."><plain>Treatment with low dose aspirin improves the live birth rate amongst women with <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> to 40% but this is further and significantly increased to 70% when they are treated with aspirin together with low-dose <z:chebi fb="5" ids="28304">heparin</z:chebi> </plain></SENT>
</text></document>